Structure Therapeutics Inc ADR (NASDAQ:GPCR) traded with an addition of $12.54 to close at $50.01on Friday, an upside of 33.45 percent. An average of 1,755,469 shares of common stock have been traded in the last five days. There was a gain of $15.74 in the past week. The last 20 days have seen an average of 867,042 shares traded, while the 50-day average volume stands at 676,881.
GPCR stock has increased by 74.17% in the last month. The company shares reached their 1-month lowest point of $27.23 on 09/08/23. Shares of the company touched a low of $20.80 and a high of $42.55 in 52 weeks. In spite of this, the price is up 17.52% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
The quick ratio of Structure Therapeutics Inc ADR for the three months ended June 29 was 15.20, and the current ratio was 15.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $1.26 million compared to revenue of $52.56 million.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$23.28 million in the quarter, while revenues of -$17.98 million were grew 100.0%. The analyst consensus anticipated Structure Therapeutics Inc ADR’s latest quarter earnings to come in at -$0.28 per share, but it turned out to be -$0.6, a -114.30% surprise. For the quarter, EBITDA amounted to -$27.56 million. Shareholders own equity worth $114.81 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Structure Therapeutics Inc ADR (GPCR) price momentum. RSI 9-day as of the close on 28 September was 89.27%, suggesting the stock is Overbought, with historical volatility in this time frame at 142.03%.
As of today, GPCR’s price is $38.00 +46.29% or $15.74 from its 5-day moving average. GPCR is currently trading +76.44% higher than its 20-day SMA and +107.25% higher than its 100-day SMA. However, the stock’s current price level is +46.77% above the SMA50.
The stochastic %K and %D were 81.89% and 82.31%, respectively, and the average true range (ATR) was 5.09. With the 14-day stochastic at 57.99% and the average true range at 4.01, the RSI (14) stands at 82.91%. The stock has reached 4.50 on the 9-day MACD Oscillator while the 14-day reading was at 6.21.
Analyst Ratings
Piper Sandler launched coverage on Structure Therapeutics Inc ADR (NASDAQ: GPCR) in its analyst report released on July 27, 2023. The firm assigned the stock an Overweight rating. The consensus rating for Structure Therapeutics Inc ADR (GPCR) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell GPCR, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is GPCR’s price target for the next 12 months?
Analysts predict a range of price targets between $40.00 and $58.00, with a median target of $48.00. Taking a look at these predictions, the average price target given by analysts for Structure Therapeutics Inc ADR (GPCR) stock is $48.50.
